Evidence map›Paper›PMID 33542902›Full record

ArticleFrontiers in oncology2020

Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/

Chengqin Wang, Runze Zhang, Xiao Wang, Yan Zheng, Huiqing Jia, Haiyan Li, Jin Wang, Ning Wang, Fenggang Xiang, Yujun Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. β-Catenin signaling in hepatocellular carcinoma.The Journal of clinical investigation · 2022
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chengqin WangDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Runze ZhangDepartment of Pathology, School of Basic Medicine, Qingdao University, Qingdao, China.
Xiao WangDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yan ZhengDepartment of Pathology, School of Basic Medicine, Qingdao University, Qingdao, China.
Huiqing JiaDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Haiyan LiDepartment of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, Qingdao, China.
Jin WangDepartment of Pathology, School of Basic Medicine, Qingdao University, Qingdao, China.
Ning WangDepartment of Pathology, School of Basic Medicine, Qingdao University, Qingdao, China.
Fenggang XiangDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yujun LiDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qingdao University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common malignant tumors in women. Kinesin family member 3B (KIF3B) is a critical regulator in mitotic progression. The objective of this study was to explore the expression, regulation, and mechanism of KIF3B in 103 cases of breast cancer tissues, 35 metastatic lymph nodes and breast cancer cell lines, including MDA-MB-231, MDA-MB-453, T47D, and MCF-7. The results showed that KIF3B expression was up-regulated in breast cancer tissues and cell lines, and the expression level was correlated with tumor recurrence and lymph node metastasis, while knockdown of KIF3B suppressed cell proliferation, migration, and invasion both

Indexed as

breast cancerDvl2epithelial mesenchymal transitionglycogen synthase kinase 3βkinesin family member 3BprogressionWnt/β-catenin signaling

Identifiers

PMID33542902
PMCPMC7851081
OpenAlexW3122613624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.